PT  - JOURNAL ARTICLE
AU  - Gilca, Rodica
AU  - Amini, Rachid
AU  - Carazo, Sara
AU  - Frenette, Charles
AU  - Boivin, Guy
AU  - Charest, Hugues
AU  - Dumaresq, Jeannot
TI  - The changing landscape of respiratory viruses contributing to respiratory hospitalisations: results from a hospital-based surveillance in Quebec, Canada, 2012-13 to 2021-22
AID  - 10.1101/2022.07.01.22277061
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.07.01.22277061
4099  - http://medrxiv.org/content/early/2022/07/02/2022.07.01.22277061.short
4100  - http://medrxiv.org/content/early/2022/07/02/2022.07.01.22277061.full
AB  - Background A comprehensive description of the combined effect of SARS-CoV-2 and respiratory viruses (RV) other than SARS-CoV-2 (ORV) on hospitalisations is lacking.Aim To compare viral etiology of acute respiratory infections (ARI) hospitalisations before and during two pandemic years from a surveillance network in Quebec, Canada.Method We compared detection of ORV and SARS-CoV-2 during 2020-21 and 2021-22 to 8 pre-pandemic influenza seasons in patients hospitalised with ARI who were tested systematically by a multiplex PCR.Results During pre-pandemic influenza seasons, overall RV detection was 92.7% (1,493) (48.3% respiratory syncytial virus (RSV)) in children and 62.8% (4,339) (40.1% influenza) in adults. Overall RV detection in 2020-21 was 58.6% (29) in children (all ORV) and 43.7% (333) in adults (3.4% ORV, 40.3% SARS-CoV2, both including coinfections). In 2021-22 overall RV detection was 91.0% (201) in children (82.8% ORV, 8.1% SARS-CoV-2, both including coinfections) and 55.5% (527) in adults (14.1% ORV, 41.4% SARS-CoV-2, both including coinfections).Virtually no influenza was detected in 2020-21 and in 2021-22 up to epi-week 2022-9 presented here; no RSV was detected in 2020-21. In 2021-22, detection of RSV was comparable to pre-pandemic years but with an unusually early season. There were significant differences in ORV and SARS-CoV-2 detection between time periods and age groups.Conclusion Significant continuous shifts in age distribution and viral etiology of ARI hospitalisations occurred during two pandemic years. This reflects evolving RV epidemiology and underscores the need for increased scrutiny of ARI hospitalisation etiology to inform tailored public health recommendations.Competing Interest StatementRG received from Abbie honorary for a conference on Respiratory Syncytial Virus burden in children unrelated to the current work. Other authors have nothing to disclosure.Funding StatementThis work was funded by the Ministry of Health of QuebecAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board approval was obtained from all participating hospitals (Hopital regional de Rimouski, Hopital de Chicoutimi, Hopital de la Cite-de-la-Sante Laval, Centre hospitalier universitaire regional de Trois-Rivieres) for the first 3 years and a signed informed consent was used. A waiver was obtained for the following years when the project was conducted as a sentinel surveillance mandated by the Ministry of Health from the Research Ethics Board of the Centre hospitalier universitaire de Quebec-Universite Laval.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors conditional on the approval of Ministry of Health of Quebec